Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002. Infection initially brings flu-like symptoms including fever and fatigue, but it then attacks ...

We ended up getting lucky with SARS. The coronavirus that caused it turned out to be far less infectious than it first ...

Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...

The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women, according to study findings.

The newest one to make people sick causes COVID-19, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first record of illness linked to SARS-CoV-2 was in China in ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Inhaled sevoflurane significantly reduced ventilator-free ...